Owen McCarty/LinkedIn
May 17, 2026, 11:04
Owen McCarty: Few Insights and Implications from Recent Clinical Trials of FXI Inhibitors
Owen McCarty, Professor and Chair at Oregon Health and Science University, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Advances in Therapy, adding:
”We summarized a few insights and implications from recent clinical trials of coagulation FXI inhibitors.”
Title: Factor XI Inhibitors in Atrial Fibrillation: Insights and Implications from Recent Trials
Authors: Rosemary B. Falama, Lisa R. Matsumoto, Marie E. Piatski, Lukas Seifer, Aditya Malhotra, Owen J. T. McCarty, Joseph J. Shatzel
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 6, 2026, 13:10Vinicius Fornazari: New Perspectives In Interventional Radiology From SOBRICE
-
Oct 6, 2026, 12:39Sarah Garvey: Putting The Patient Experience At The Heart Of VTE Care
-
Oct 6, 2026, 12:33Platelets Without Donors: Can Freeze-Dried Artificial Platelets Transform Trauma Care?
-
Oct 6, 2026, 12:03Louise St. Germain Bannon: Supporting the World Thrombosis Day
-
Oct 6, 2026, 11:39Joining the Hemophilia and Bleeding Disorders Community at the EHC 2026 – WFH
-
Oct 6, 2026, 10:56Moustafa Abdou: LE Cells and the Early Diagnosis of Lupus
-
Oct 6, 2026, 10:35Caitlin Raymond: Understanding IgA Deficiency and Anaphylaxis Risk
-
Oct 6, 2026, 10:15Zeeshan Ali Baig: AI-Designed Peptide for Rare Bleeding Disorder
-
Oct 6, 2026, 10:12Srivatsan Rangachari: Stem Cell Transplant for 12-Year-Old with Fanconi Anaemia